View in EDS

Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.

Saved in:
Bibliographic Details
Title: Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.
Authors: Gelmon KA; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada. Electronic address: kgelmon@bccancer.bc.ca., Fasching PA; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Balmaña J; Department of Medical Oncology, Hospital Universitari Vall d'Hebron and Vall d'Hebron Institute of Oncology, Passeig de la Vall d'Hebron, Barcelona, Spain., Delaloge S; Breast Cancer Unit, Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Labidi-Galy I; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland., Bennett J; AstraZeneca, Cambridge, UK., McCutcheon S; AstraZeneca, Cambridge, UK., Walker G; AstraZeneca, Cambridge, UK., O'Shaughnessy J; Baylor University Medical Centre, Texas Oncology and US Oncology, Dallas, TX, USA.
Corporate Authors: Collaborating Investigators
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jul; Vol. 152, pp. 68-77. Date of Electronic Publication: 2021 Jun 01.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34087573
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gelmon+KA%22">Gelmon KA</searchLink>; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada. Electronic address: kgelmon@bccancer.bc.ca.<br /><searchLink fieldCode="AU" term="%22Fasching+PA%22">Fasching PA</searchLink>; Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Couch+FJ%22">Couch FJ</searchLink>; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Balmaña+J%22">Balmaña J</searchLink>; Department of Medical Oncology, Hospital Universitari Vall d'Hebron and Vall d'Hebron Institute of Oncology, Passeig de la Vall d'Hebron, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Delaloge+S%22">Delaloge S</searchLink>; Breast Cancer Unit, Department of Cancer Medicine, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Labidi-Galy+I%22">Labidi-Galy I</searchLink>; Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bennett+J%22">Bennett J</searchLink>; AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22McCutcheon+S%22">McCutcheon S</searchLink>; AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Walker+G%22">Walker G</searchLink>; AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22O'Shaughnessy+J%22">O'Shaughnessy J</searchLink>; Baylor University Medical Centre, Texas Oncology and US Oncology, Dallas, TX, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Collaborating+Investigators%22">Collaborating Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2021 Jul; Vol. 152, pp. 68-77. <i>Date of Electronic Publication: </i>2021 Jun 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34087573
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2021.03.029
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 68
    Titles:
      – TitleFull: Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gelmon KA
      – PersonEntity:
          Name:
            NameFull: Fasching PA
      – PersonEntity:
          Name:
            NameFull: Couch FJ
      – PersonEntity:
          Name:
            NameFull: Balmaña J
      – PersonEntity:
          Name:
            NameFull: Delaloge S
      – PersonEntity:
          Name:
            NameFull: Labidi-Galy I
      – PersonEntity:
          Name:
            NameFull: Bennett J
      – PersonEntity:
          Name:
            NameFull: McCutcheon S
      – PersonEntity:
          Name:
            NameFull: Walker G
      – PersonEntity:
          Name:
            NameFull: O'Shaughnessy J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2021 Jul
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 152
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1